# Using Chronobiology to Improve Lenvatinib Efficacy

> **NCT06321120** · EARLY_PHASE1 · UNKNOWN · sponsor: **Hadassah Medical Organization** · enrollment: 10 (estimated)

## Conditions studied

- Lenvatinib Treatment

## Interventions

- **DRUG:** variability-based lenvatinib regimen

## Key facts

- **NCT ID:** NCT06321120
- **Lead sponsor:** Hadassah Medical Organization
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2024-04
- **Final completion:** 2024-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06321120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06321120, "Using Chronobiology to Improve Lenvatinib Efficacy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06321120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*